Scientists launch national study to track immune weakness linked to severe COVID
NCT ID NCT06762002
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study follows 500 adults in France who have either a genetic defect or autoantibodies that weaken their type I interferon immune response. Researchers will collect blood samples and health data over 1 to 4 years to track infections, autoimmune diseases, and cancers. The goal is to better understand and manage these immune deficiencies, but no new treatments are being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors monitor and manage patients with type I interferon deficiencies, potentially reducing severe infections.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly cure or treat any disease, and results may take years to translate into clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cic Bichat
RECRUITINGParis, France
-
Cic Creteil
RECRUITINGParis, France
-
Cic La Salpetriere
RECRUITINGParis, France
-
Cic Lille
RECRUITINGLille, France
-
Cic Montpellier
RECRUITINGMontpellier, France
-
Cic Necker
RECRUITINGParis, France
-
Cic St Louis
RECRUITINGParis, France
-
Cic Tours
RECRUITINGTours, France
-
LYON HCL
RECRUITINGLyon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Putting dietitians in charge of hospital nutrition: a recipe for shorter stays?
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Gene hunt in children could unlock secrets of rare metabolic diseases
- Eye insert could ease allergy symptoms for contact lens wearers
- Mystery autumn allergies traced to birch rust?